Scientific & Regulatory Consulting•Toxicology & Product Safety
Request basket0
PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Glycerol→

Glycerol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
56-81-5
Molecular formula
C3H8O3
Molecular weight
92.09 g/mol
Drug class
Hyperosmotic laxativeosmotic agent
Mechanism of action
Retains water in the rectum by an osmotic effect and may also mildly irritate the lower bowel, promoting peristalsis and evacuation. Rectal glycerol also has lubricating and stool-softening effects.
Indications / reported uses
  • Short-term relief of occasional constipation with rectal suppository or enema formulations.
  • Other uses, such as reduction of intraocular pressure, are formulation- and route-specific.

Sources: https://www.medicines.org.uk/emc/product/3534/smpc · https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?audience=consumer&setid=4694f05b-d927-4e15-9630-a0a1cddb3cbb

View request basketPrefer email? [email protected]
PDE / ADE derivationOEL derivationOEB / OHC bandingRequest basket0
Substance information

Drug class, mechanism of action and general use cases

Drug class

Hyperosmotic laxative; osmotic agent

Mechanism of action

Retains water in the rectum by an osmotic effect and may also mildly irritate the lower bowel, promoting peristalsis and evacuation. Rectal glycerol also has lubricating and stool-softening effects.

General use cases

  • Short-term relief of occasional constipation with rectal suppository or enema formulations.
  • Other uses, such as reduction of intraocular pressure, are formulation- and route-specific.

For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.

Assessment scope

Project-specific PDE/ADE and OEL/OEB support

Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.

  • PDE/ADE: critical effects, point of departure and justified adjustment factors.
  • OEL: inhalation hazards, exposure duration and workplace conditions.
  • OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
  • Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope

PDE/ADE and OEL/OEB assessment

ReguSight provides project-specific support for Glycerol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Glycerol Permitted Daily Exposure (PDE) report (the Glycerol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Glycerol Occupational Exposure Limit (OEL) report (the Glycerol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.